The impact of BK virus on the renal transplant recipient

Current Opinion in Organ Transplantation

Volumn 6, Issue 4, 2001, Pages 290-294

  Soave, Rosemary ^a   Marotta, Mario ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BROXURIDINE; CIDOFOVIR; CYTIDINE; GYRASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; NUCLEOSIDE ANALOG; RECOMBINANT ALPHA INTERFERON; RETINOIC ACID; VIDARABINE;

BK VIRUS; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; HEALTH SURVEY; HEMORRHAGIC CYSTITIS; HUMAN; IN VITRO STUDY; INCIDENCE; KIDNEY ALLOGRAFT REJECTION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; NEPHROTOXICITY; NONHUMAN; PATHOGENICITY; PATHOPHYSIOLOGY; PATIENT MONITORING; POLYMERASE CHAIN REACTION; POLYOMA VIRUS; QUALITATIVE DIAGNOSIS; QUANTITATIVE ASSAY; REVIEW; SENSITIVITY AND SPECIFICITY; VIRUS INFECTION; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0035688057     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075200-200112000-00003     Document Type: Review

References (76)

1. Polyomaviruses
2. JC, BK, and other polyomaviruses: Progressive multifocal leukoencephalopathy
3. New human papovavirus (B.K.) isolated from urine after renal transplantation
4. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy
5. Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients
6. Human polyomavirus BKV and renal disease
7. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland
8. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage
9. The persistence of papovavirus BK DNA sequences in normal human renal tissue
10. BK virus: A clinical review
11. Polyomavirus persistence in lymphocytes: Prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion center
12. Identification of archetype and rearranged forms of BK virus in leukocytes from healthy individuals
13. BK and JC human polyomaviruses and simian virus 40: Natural history of infection in humans, experimental oncogenicity, and association with human tumors
14. New aspects in the pathogenesis of polyomavirus-induced disease
15. Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals
16. Presence of human polyomavirus DNA in the peripheral circulation of bone marrow transplant patients with and without hemorrhagic cystitis
17. Polyomavirus latency and human tumors
18. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals
19. Different genotypes of human polyomaviruses found in patients with autoimmune diseases in Taiwan
20. Evidence for reactivation of persistent infection during pregnancy and lack of congenital transmission of BK virus, a human papovavirus
21. High incidence of urinary JC virus excretion in nonimmunosuppressed older patients
22. Survey of human polyomaviruses (JCV, BKV) infections in 139 patients with lung cancer, breast cancer, melanoma, or lymphoma
23. Latency and reactivation of JC virus in peripheral blood of human immunodeficiency type 1-infected patients
24. Occurrence and significance of papovaviruses BK and JC in the urine
25. Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation
26. A prospective study of human polyomavirus infection in pregnancy
27. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host
28. JC virus infection in allograft kidneys: Analysis by polymerase chain reaction and immunohistochemistry
29. Molecular biology and pathogenesis of human polyomavirus infections
30. High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes
31. BK virus as a potential co-factor in human cancer
32. BK virus infection in AIDS
33. BK and JC viruses in patients with systemic lupus erythematosus: Prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia
34. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS
35. Human polyomavirus BK (BKV) load and hemorrhagic cystitis in bone marrow transplantation patients
36. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants
37. Clinical course and treatment of hemorrhagic cystitis associated with BK type of human polyomavirus in nine pediatric recipients of allogeneic bone marrow transplants
38. Human polyomavirus infections with JC virus and BK virus in renal transplant patients
39. A serological investigation of BK virus and JC virus infections in recipients of renal allografts
40. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients
41. Human polyoma virus (HPV) - A significant pathogen in renal transplantation
42. Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients
43. Diagnosis and management of BK polyomavirus interstitial nephritis in renal transplant recipients
44. Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection
45. Renal failure due to BK virus infection in an immunodeficient child
46. Molecular characterization of sequence analysis of polyomavirus BKV-strain in a renal-allograft recipient
47. A regulatory region rearranged BK virus is associated with tubulointerstitial nephritis in a rejected renal allograft
48. Nephropathy due to polyomavirus type BK
49. Human polyoma virus-associated interstitial nephritis in the allograft kidney
50. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy
51. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game
52. Polyomavirus disease under new immunosuppressive drugs
53. Human polyoma virus in renal allograft biopsies: Morphologic findings and correlation with urine cytology
54. BK virus infection in a kidney allograft diagnosed by needle biopsy
55. Polyomavirus-induced interstitial nephritis in two renal transplant recipients: Case reports and review of the literature
56. Renal dysfunction and hyperglycemia in a renal transplant recipient
57. Polyomavirus infection and disease in renal transplant recipients
58. Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infection in response to cellular damage and regeneration
59. Polyomaviruria in renal transplant patients is not correlated to the cold ischemia period or to rejection episodes
60. Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction
61. BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions
62. Prevalence and distribution of BK virus subtypes in healthy people and immunocompromised patients detected by PCR-restriction enzyme analysis
63. Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products
64. Regulatory DNA sequence conserved in the course of BK virus evolution
65. At least two types of control regions can be found among naturally occurring BK virus strains
66. Tubulointerstitial nephritis due to a mutant polyomavirus BK virus strain, BKV(Cin), causing end-stage renal disease
67. Effect of immunosuppression on the urinary excretion of BK and JC polyomaviruses in renal allograft recipients
68. Association between polyomaviruria and microscopic haematuria in bone marrow transplant recipients
69. Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction
70. Quantitation of BK virus load in serum for the diagnosis of BK virus-associated nephropathy in renal transplant recipients
71. Activities of various compounds against murine and primate polyomaviruses
72. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase
73. Interferon and BK papovavirus - Clinical and laboratory studies
74. Cidofovir treatment of human polyomavirus-associated acute hemorrhagic cystitis
75. Treatment of BK virus-associated hemorrhagic cystitis and simultaneous CMV reactivation with cidofovir
76. The use of vidarabine in the treatment of human polyomavirus associated acute hemorrhagic cystitis